CVS will shut down clin­i­cal tri­als unit that it launched dur­ing Covid

CVS Health is shut­ting down the clin­i­cal tri­als busi­ness that it launched just two years ago, part of an ef­fort to fo­cus on its core busi­ness.

CVS con­firmed the move in a state­ment:  “We con­tin­u­al­ly eval­u­ate our port­fo­lio of as­sets to en­sure they are aligned with our long-term strate­gic pri­or­i­ties,” a spokesman for the com­pa­ny said in a text. “We’re wind­ing down our Clin­i­cal Tri­al Ser­vices busi­ness in a phased way, with a full ex­it ex­pect­ed by De­cem­ber 31, 2024.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA